EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma

Jia-Qi Zhu iD, Han Wu, Xu Li, Min-Yu Li, Zhen-Li Li, Xin-Fei Xu, Li-Hui Gu, Dong-Xu Yin, Feng Shen, Dong-Sheng Huang, Tian Yang iD

Advanced Science · 2024

DOI: 10.1002/advs.202305508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Jia-Qi Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nanoparticles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Dawn Project Foundation of Shanghai, Shanghai Health and Hygiene Discipline Leader Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is acknowledged as an immunosuppressive neoplasm, whereby the inactive microenvironment facilitates immune tolerance and evasion of HCC. Post‐surgical resected liver cancer exhibits a proclivity for relapse, rendering prevention of recurrence challenging as it may transpire at any point subsequent to surgery. Among the various anti‐recurrence interventions, the primary clinical approach involving the administration of regimens atezolizumab and bevacizumab (A+T) is deemed the most efficacious in reversing the tumor microenvironment, albeit still lacking in complete satisfaction. Therefore, the objective is to utilize a recently developed block copolymer as a protective carrier for two specific monoclonal antibody drugs. Subsequently, a modified hemostatic hydrogel will be synthesized for application during hepatic surgery. The immunotherapy impact of this approach is significantly prolonged and intensified due to the combined hemostasis properties and controlled release of the constituents within the synthesized nanocomposite hydrogel. Furthermore, these nanocomposite hydrogels exhibit remarkable efficacy in preventing postoperative wound bleeding and substantially enhancing the safety of liver cancer resection. This research on the anti‐recurrence hydrogel system presents a novel therapeutic approach for addressing local recurrence of liver cancer, potentially offering a substantial contribution to the field of surgical treatment for liver cancer in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNanoparticlesHumansBlood Loss, SurgicalHydrogelsNeoplasm Recurrence, LocalTumor Microenvironment

Stichwörter der Autor:innen

adhesive hydrogelsblock copolymerhepatocellular carcinomaimmunotherapytumor recurrence

Substanzen

Hydrogels

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, 200438, China.
  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, China.
  • Department of Colorectal Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
  • Department of Special Care Unit, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
  • School of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
  • The Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China.

ORCID-Profile: Jia-Qi Zhu, Tian Yang

Förderung

  • National Natural Science Foundation of China
  • Dawn Project Foundation of Shanghai
  • Shanghai Health and Hygiene Discipline Leader Project
  • the Special sailing project of Shanghai Science and Technology Innovation Action Plan
  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Zitieren

APA

Zhu, J. Q., Wu, H., Li, X., Li, M. Y., Li, Z. L., Xu, X. F., Gu, L. H., Yin, D. X., Shen, F., Huang, D. S., & Yang, T. (2024). Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202305508

Vancouver

Zhu JQ, Wu H, Li X, Li MY, Li ZL, Xu XF, et al. Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma. Advanced Science. 2024. doi:10.1002/advs.202305508

BibTeX
@article{Zhu2024,
  author = {Zhu, Jia-Qi and Wu, Han and Li, Xu and Li, Min-Yu and Li, Zhen-Li and Xu, Xin-Fei and Gu, Li-Hui and Yin, Dong-Xu and Shen, Feng and Huang, Dong-Sheng and Yang, Tian},
  title = {Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202305508}
}
Kostenlos starten →